Ɗaya daga cikin mafi ban mamaki "tambayoyin gaskiya" na gani zuwa yanzu shine Wannan daga wani kanti na musamman mara hankali da ake kira Labaran Jagora. Da alama an haɗa shi ne don mayar da martani ga labarai masu tasowa na wani jami'in zartarwa na Pfizer yana mai cewa ba a taɓa gwada maganin su na Covid-19 don ingancin yaduwa ba. Rob Roos, memba na Majalisar Tarayyar Turai ya raba martanin bangaren zartarwa Twitter, tare da nasa tsokaci.
Wannan ci gaban binciken wani Madison Dapcevich ne ya rubuta shi, wanda ke da digiri na biyu a fannin kimiyyar muhalli da aikin jarida na albarkatun kasa daga Jami'ar Montana. Don haka, a fili babban ƙwararren likita.
Wannan shine kanun labaran Dapcevich:
"Binciken Gaskiya: Gwajin Asibitin Alurar riga kafi na Pfizer BA'A Nufin Gwajin Rigakafin Watsawa ba - Wannan Ba Yadda Gwajin Asibitin Ke Aiki ba"
Kamar yadda Dapcevich yayi bayani:
"Shin wakilin Pfizer" ya yarda" kamfanin ya yi kuskure lokacin da ba a taɓa gwada rigakafin cutar ta COVID-19 ba kan hana watsa kwayar cutar yayin gwajin asibiti? A'a, wannan ba gaskiya bane. gwaje-gwaje, a cewar kwararrun rigakafin A wannan yanayin, an tantance ikon rigakafin na rigakafi daga baya a fitar da maganin, wanda aka kirkira don mayar da martani ga annoba ta duniya.
Da farko, wakilin Pfizer ya ce ba a gwada allurar rigakafin cutar ba. Don haka a fili gaskiya ne wakilin ya fadi haka. Gaskiyar cewa marubucin tweet, wanda Dapcevich yayi amfani da shi a matsayin wurin farawa don "tabbacin gaskiya", a fili ya yarda da wakilin Pfizer; Yin amfani da kalmar "ya yarda", banda batun: Tambayar ita ce, idan wakilin ya faɗi haka. Ta yi. Dapcevich ba daidai ba ce ta ce ba ta yi ba.
Na biyu, babban jami'in Pfizer ko dan majalisar ba su taba cewa kamfanin ya yi "kuskure" ta hanyar yin gwaji ba idan rigakafin su ya iyakance watsawa. Wannan shi ne abin da Dapcevich ke da shi, wanda ya saba da tsarin bambaro da ita da irinta ke amfani da ita.
Daga nan Dapcevich ya ci gaba da da'awar cewa gwajin rigakafin ba ana nufin gwajin yaduwa ba ne, yayin da a lokaci guda ya ce an yi nufin bincika ingancin kamuwa da cuta:
"Yayin da aka nuna allurar Pfizer da Moderna don karewa daga cututtuka da cututtuka masu tsanani, Ƙungiyar Ƙwararrun Ƙwararrun Ƙwararrun Amirka. bayanin kula Gwajin asibiti na rigakafin ba a “tsara su don gwada ko ɗaya daga cikin mahalarta gwajin ya yi kwangilar COVID-19 amma bai nuna alamun ba.”
A takaice, gwaje-gwajen da suka gwada aminci da ingancin rigakafin ba a tsara su don gwada watsawa a wani bangare ba saboda girman gwajin da tsawon lokaci zai buƙaci ya fi girma da tsayi kuma makasudin shine hana mutuwa. "
Dalilin yana da ban sha'awa: Marubucin ya faɗi da'awar cewa gwaje-gwajen ba su gwada kamuwa da cutar asymptomatic ba. Daga nan ta yanke shawarar cewa hakan na da nasaba da “Trial size and duration” wanda ko kadan ba a bayyana a cikin jigon ta ba, da kuma cewa “manufa ita ce ta hana mace-mace” wacce ita ma ba a bayyana ba kuma ba shakka karya ce ga duk wanda ya karanta binciken. Ƙarshe ta ƙarshe ita ce gwajin rigakafin ba ya gwada yaduwa kwata-kwata. Ba wai kawai Dapcevich hukuma ce da ba a gardama kan magani ba, a fili tana da ƙwarewa ta musamman na ma'ana.
A cikin duniyar gaske duk da haka, idan yazo ga alluran rigakafi, inganci shine daidai game da kamuwa da cuta; ko maganin yana hana kamuwa da cuta ko a'a. Kuma wannan shine ainihin abin da aka gwada a lokacin Gwajin Pfizer. A cikin kalmomin marubutan:
"Batun ƙarshen farko na farko shine ingancin BNT162b2 akan tabbatar da Covid-19 tare da farawa aƙalla kwanaki 7 bayan kashi na biyu a cikin mahalarta waɗanda ba su da shaidar serologic ko virologic na kamuwa da cutar SARS-CoV-2 har zuwa kwanaki 7 bayan kashi na biyu; na biyu na ƙarshen ƙarshen ƙarshen shine inganci a cikin mahalarta tare da mahalarta ba tare da shaidar kamuwa da cuta ta farko ba. kasancewar aƙalla ɗaya daga cikin alamun masu zuwa: zazzabi, sabon ko tari, sabon ko ƙarar numfashi, sanyi, sabon ko ƙarar tsoka zafi, sabon hasara ko wari, ciwon makogwaro, zawo, ko amai, haɗe tare da samfurin numfashi da aka samu yayin lokacin bayyanar cututtuka ko cikin kwanaki 19 kafin ko bayan sa wanda ya kasance tabbatacce ga SARS-CoV-4 ta hanyar haɓakar acid-CoV-2 ta hanyar ƙarawa na tsakiya ko gwajin gwaji na gida. gwajin yarda da ƙayyadaddun ƙa'ida)."
...
"Daga cikin mahalarta 36,523 waɗanda ba su da shaidar kasancewar ko kafin kamuwa da cutar ta SARS-CoV-2, lokuta 8 na Covid-19 tare da farawa aƙalla kwanaki 7 bayan an lura da kashi na biyu tsakanin masu karɓar alurar rigakafi da 162 a cikin masu karɓar placebo. Wannan shari'ar ta raba daidai da 95.0% ingancin rigakafin (95% zuwa CI). Table 2). "
"A cikin yanayin da ake ciki a halin yanzu, har yanzu ana ci gaba da yaduwar cutar, rigakafin BNT162b2, idan an amince da shi, na iya ba da gudummawa, tare da sauran matakan kiwon lafiyar jama'a, don rage mummunar asarar lafiya, rayuwa, da tattalin arziki da walwalar jama'a wanda ya haifar da yaduwar Covid-19 a duniya."
A takaice dai, gwajin ya kasance game da bincika "tabbatar da Covid-19" ta kasancewar aƙalla ɗaya daga cikin alamun da ke tabbatar da kamuwa da cutar ta Covid-19 kuma ƙarshe shine cewa maganin zai taimaka kawo ƙarshen cutar.
Gaskiya ne cewa cututtukan asymptomatic, a lokacin da aka yi imani sun kasance har zuwa rabi na duk cututtuka, ba a duba su a cikin gwaji ba. Hakanan gaskiya ne cewa a ƙarshen 2020 Shugaban Kamfanin Pfizer Albert Bourla ya bayyana damuwarsa cewa maganin na iya hana yaduwar asymptomatic. Amma wannan ba yana nufin ba a ƙirƙira gwajin don bincika kamuwa da cuta ba don haka don watsawa. Yana nufin kawai cak ɗin ya kasance bangare ne, bai cika ba.
Saboda haka da'awar Dapcevich, ta bayyana a cikin kanun labarai kuma ta maimaita sau da yawa a cikin labarin, cewa gwajin asibiti ba a yi nufin "Ba a yi nufin gwada rigakafin watsawa ba" kuma "Ba haka ba ne yadda Gwajin Asibiti ke Aiki" ba daidai ba ne.
Akasin haka, farkon ƙarshen binciken yana da alaƙa da kamuwa da cuta kuma ba tare da kamuwa da cuta ba ba za a sami yaduwa ba. Kuma kamar yadda muka gani a cikin nassi na ƙarshe, daga sashin tattaunawa na binciken, marubutan har ma sun bayyana yadda allurar za ta rage, ba kawai asarar lafiya da rayuwa ba, har ma da "tattalin arziki da jin daɗin rayuwa." Wannan yana nufin marubutan sun yi imanin cewa binciken ya nuna cewa ta hanyar yin allurar rigakafin Covid-19 za a iya sauƙaƙe hanyoyin magance su, wanda hakan ke nufin sun yi imanin cewa maganin zai hana yaduwa.
Babu tambaya akan hakan a lokacin. Yan siyasa da masu yada farfaganda irinsu Anthony Fauci ya ci gaba da bayyana cewa kawai abin da ke hana tasiri daga fassara zuwa tasiri na duniya shine shiga cikin shirye-shiryen rigakafin.
Menene ainihin labarin to? A yayin sauraron karar, wakilin Pfizer ya ce ba a taba bincikar raguwar watsawa ba. Amma kamar yadda binciken gwaji ya nuna, an duba wannan; shi ne farkon ƙarshen binciken.
Akwai mahimman hanyoyin da za a ɗauka:
Na farko, marubucin labarin binciken gaskiya ya yi iƙirarin kuskure cewa gwajin asibiti na alluran ba a yi nufin gwada rigakafin watsawa ba.
Na biyu, ta ƙara kalmar “kuskure” a cikin bayanin Roos, marubucin ya “bincika gaskiya” maganar da ba a taɓa yin ba.
Na uku, babban jami'in Pfizer ya yi kuskure don da'awar a cikin sauraron cewa ba a taɓa gwada watsawa ba. Ya kasance, kuma wannan shine babban dalilin shari'ar. Kanun labarai da ya dace don haka zai karanta:
"Binciken Gaskiya: Babban Jami'in Pfizer yayi iƙirari Ba daidai ba ne rigakafin cutarwa ba a gwada shi ba a cikin gwaji na asibiti - Abin da aka yi daidai ke nan"
Tambayar ta kasance idan gwajin Pfizer ya kasance da kuskure da/ko rashin gaskiya na kamfanin. An yi amfani da sakamakon gwajin tun daga farko don tabbatar da hare-haren da ake kaiwa da kuma ware mutanen da ba a ba da su ba, na dogon lokaci da'awar 95% na inganci da aka yi amfani da shi don tallafawa alurar riga kafi, kuma waɗanda suka yi shakkar wannan, suna nuna ainihin bayanai, nan da nan ya zama makasudin "masu bincike na gaskiya" kamar Madison Dapcevich, kuma an ba da su ta hanyar kafofin watsa labarun kuma an ba da su ta hanyar kafofin watsa labarun. ware.
Pfizer bai taba ba da wani bayani game da tsarin ba, amma a maimakon haka ya yi alfahari game da yadda harbin nasu zai kawo karshen cutar. Bugu da ƙari, kamar yadda a lokacin an riga an yi imani da cewa kusan kashi 50% na waɗanda suka kamu da cutar ba su taɓa nuna alamun cutar ba, an riga an sami dalili mai ƙarfi don amfani da gwajin pcr maimakon kawai bincika alamun a cikin gwaji.
Don haka, shin kamfanin "kuskure" bayan duk? Yana iya da kyau a ce ya yi, kuma watakila ba bisa kuskure ba, amma da niyya. Shin ’yan siyasa sun yi kuskure, masu yada farfaganda, kafafen yada labarai? Shin masu binciken gaskiya sun yi kuskure? Lallai sun yi, sun kiyaye, kuma da gangan suka aikata.
-
Thorsteinn Siglaugsson mashawarcin Icelandic ne, ɗan kasuwa kuma marubuci kuma yana ba da gudummawa akai-akai ga The Daily Skeptic har ma da wallafe-wallafen Icelandic daban-daban. Ya yi digiri na BA a fannin falsafa da MBA daga INSEAD. Thorsteinn ƙwararren ƙwararren ƙwararren ƙwararren ne a cikin Theory of Constraints kuma marubucin Daga Alamu zuwa Dalilai - Aiwatar da Tsarin Tunanin Hankali zuwa Matsala ta Kullum.
Duba dukkan posts
